Skip to main content
. Author manuscript; available in PMC: 2015 May 8.
Published in final edited form as: Antivir Ther. 2014 Aug 8;20(2):199–208. doi: 10.3851/IMP2821

Figure 3. Number of resistance mutations in the NS3 protease gene, within each participant, exhibited at > 0.1% frequency.

Figure 3

The occurrence of at least one acid change known to confer resistance was included as varation at that site. Individuals demonstrated a range of the number of resistance mutations found >0.1% (0 – 9 sites).